Compounds > hydroxyproline

Page last updated: 2024-08-17

hydroxyproline and tamoxifen

hydroxyproline has been researched along with tamoxifen in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	3 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, W; Gold, E; Goulding, A	1
Fisher, L; Gold, E; Goulding, A	1
McDonald, MW; Neely, CL; Niell, HB; Palmieri, GM	1
Coombes, RC; Dady, P; Ford, HT; Gazet, JC; McCready, VR; Parsons, C; Powles, TJ	1
Dalley, D; Kelly, PJ; Morgan, G; Ward, RL	1
Carney, KR; Jimenez, SA; Mendoza, FA; Piera-Velazquez, S; Wermuth, PJ	1

Trials

1 trial(s) available for hydroxyproline and tamoxifen

Article	Year
Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women. Bone and mineral, 1993, Volume: 22, Issue:2 Topics: Absorptiometry, Photon; Administration, Oral; Bone Density; Breast Neoplasms; Female; Femur Neck; Humans; Hydroxyproline; Lumbar Vertebrae; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Tamoxifen	1993

Other Studies

5 other study(ies) available for hydroxyproline and tamoxifen

Article	Year
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin. Bone and mineral, 1992, Volume: 18, Issue:2 Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Disease Models, Animal; Drug Interactions; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Organ Size; Rats; Rats, Inbred Strains; Tamoxifen; Uterus	1992
Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet. Bone and mineral, 1990, Volume: 8, Issue:3 Topics: Animals; Bone Resorption; Calcitriol; Calcium; Calcium Radioisotopes; Clomiphene; Diet; Dose-Response Relationship, Drug; Female; Hydroxyproline; Ovary; Parathyroid Glands; Parathyroid Hormone; Rats; Rats, Inbred Strains; Tamoxifen	1990
The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer. Cancer, 1983, Oct-15, Volume: 52, Issue:8 Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Hydroxyproline; Middle Aged; Radiography; Tamoxifen; Time Factors	1983
Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer, 1983, Aug-15, Volume: 52, Issue:4 Topics: Alkaline Phosphatase; Aminoglutethimide; Antineoplastic Agents; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Danazol; Doxorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Radiography; Tamoxifen; Time Factors; Vincristine	1983
Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis. Laboratory investigation; a journal of technical methods and pathology, 2017, Volume: 97, Issue:7 Topics: Animals; Endothelial Cells; Female; Fibrosis; Hydroxyproline; Immunohistochemistry; Lung; Male; Mice; Mice, Transgenic; Microscopy, Confocal; Organ Specificity; Signal Transduction; Tamoxifen; Transforming Growth Factor beta	2017